| Name | NLRP3-IN-25 |
|---|
| Description | NLRP3-IN-25 (compound 32) is an orally available NLRP3 inhibitor with anti-inflammatory activity. NLRP3-IN-25 attenuates renal injury in doxorubicin-induced glomerulonephritis in mice. NLRP3-IN-25 inhibits IL-1β secretion in THP-1 cells with an IC50 of 21 nM[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C17H19F3N4O5S |
|---|---|
| Molecular Weight | 448.42 |